{"text": "biib below avg volume daily appearances since 2010 287 close 5 days later avg 0 66 sd 10 95 worst 80 31 best 50 59 10 days later avg 1 35 sd 15 87 worst 84 75 best 65 00 30 days later avg 1 75 sd 26 66 worst 103 76 best 58 86"}
{"text": "biib when it busts out of its channel looking for measured move to 330"}
{"text": "interesting looks like ions is developing a 2nd aso for parkinson s disease to target synuclein there is a ph2 drug partnered with biib targeting leucine rich repeat kinase 2 lrrk2"}
{"text": "maybe some vividness bias too lot of chtr bulls here and that one hasn t worked out yet a few folks pounding the table on biib too definitely far more hits than misses though some really well like iac par qrtea but not totally unexpected in a bull market"}
{"text": "biib biogen ec has granted marketing authorization for a subcutaneous injection of tysabri to treat"}
{"text": "biib high oi range is 200 00 to 285 00 for option expiration 04 09 2021 putcallratio 1 21 maxpain options"}
